Stocks On The Move: Pfizer, Altria...
Following are the week’s biggest winners and losers. Find out why shares of Pfizer (PFE) and Altria (MO) popped while McDonald's (MCD) and Juniper (JNPR) dropped.
POPS (stocks that jumped higher)
Pfizer (PFE) popped 5%. Big pharma surged higher all throughout the JP Morgan Health Care conference. I think this stock will pop for the rest of the year, says Guy Adami.
Altria (MO) popped 6%. Defensive names such as Altria were in vogue in a volatile week. – This is as defensive as you get, says Karen Finerman.
Plastic Surgery Gift Cards. What to get for the trophy wife that has everything? Dr. Lloyd Krieger of "Rodeo Drive Plastic Surgery" is using a familiar merchandising tactic to boost sales of nips and tucks. His office now sells gift cards.
Amgen (AMGN) popped 6%. Biotech names were among the beneficiaries of merger talk, inspired by the JP Morgan Health Care Conference.
DROPS (stocks that slid lower)
McDonald's (MCD) dropped 5%. A Friedman, Billings, Ramsey analyst said McDonald's shares were "fully valued" and forecast the stock would trade at the $53-dollar level by next year. – Cut them some slack, says Jeff Macke and buy the dip.
Juniper (JNPR) dropped 14%. Stephen Elop, COO of the computer networking firm, announced he was stepping down. Elop was credited was increasing margins and helping to make Juniper a viable competitor to Cisco.
AllianceBernstein (AB) dropped 6%. Lower hedge fund fees sent this asset manager on its largest single-day share drop ever. – There are a lot of great names in the space, but I don’t think this is one of them, says Guy Adami.
Intel (INTC) dropped 3%. Still reeling from last week's downgrades, Intel slid lower ahead of its earnings next week. – Buy this dip, says Jeff Macke.
RF Micro Devices (RFMD) dropped 29%. The maker of chips for cell phones said slumping demand led it to miss forecasts for sales and profits. – Forget the chip market, says Pete Najarian.
Big 5 Sporting Goods (BGFV) dropped 18%. This athletic equipment retailer posted profits and sales well below expectations. – Stay away, says Karen Finerman.
Jamba Juice (JMBA) dropped 10%. The smoothie store got squeezed -- revenues missed estimates. – Get out, says Jeff Macke.
Got something to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to firstname.lastname@example.org.
Trader disclosure: On Jan 11, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders Macke Owns (YHOO), (INTC): Najarian Owns (BIIB), (C), (CSCO), (MCD), (MSFT); Najarian Owns (AAPL) Options, (CFC) Options, (VLO) Options, (YHOO) Options, (WM) Options: Finerman Owns (GS); Finerman's Firm Owns (YHOO), (DSW), (WMT); Finerman's Firm Owns (LEH) Puts; Finerman's Firm Owns S&P 500 Puts; Finerman's Firm Owns (MDY) Puts And Is Short (MDY); Finerman's Firm Owns Russell 2000 Puts; Finerman's Firm Owns (MSFT) Options; Finerman's Firm Owns (CROX) And (CROX) Options; Finerman's Firm Is Short (IYR), (IWM), (SPY)